Inventor · disambiguated record
Gurmit Grewal
Also filed as: GREWAL GURMIT · GREWAL GURMIT S · GREWAL GURMIT SINGH
16 granted patents·8 pending applications·246 citations·filing 1994–2024
94Inventor score
Files withUCB SA9ASTRAZENECA AB4CYTOMED INC4BRIGHAM & WOMENS HOSPITAL INC2LYNK PHARMACEUTICALS CO LTD2
Top patents by PatentIndex Score
24 records- 0187US9682983B2BMP inhibitors and methods of use thereofBRIGHAM & WOMENS HOSPITAL INC·Filed 2014·Granted Jun 20, 2017·10 cites·19 claims
- 0287US5463083ACompounds and methods for the treatment of cardiovascular, inflammatory and immune disordersCYTOMED INC·Filed 1994·Granted Oct 31, 1995·67 cites·27 claims
- 0386US6423842B1Muscarinic agonists and antagonistsUCB SA·Filed 2001·Granted Jul 23, 2002·20 cites·3 claims
- 0484US5741809ACompounds and methods for the treatment of cardiovascular inflammatory and immune disordersCYTOMED INC·Filed 1995·Granted Apr 21, 1998·55 cites·7 claims
- 0581US10017516B2BMP inhibitors and methods of use thereofBRIGHAM & WOMENS HOSPITAL INC·Filed 2017·Granted Jul 10, 2018·3 cites·5 claims
- 0680US6555550B1Musarinic agonists and antagonistsUCB SA·Filed 2002·Granted Apr 29, 2003·9 cites·3 claims
- 0779US6323194B1Muscarinic agonists and antagonistsUCB SA·Filed 2000·Granted Nov 27, 2001·10 cites·8 claims
- 0878US6251916B1Muscarinic agonists and antagonistsUCB SA·Filed 2000·Granted Jun 26, 2001·9 cites·6 claims
- 0976US6451801B1Compounds and methods for treatment of asthma, allergy and inflammatory disordersUCB SA·Filed 2000·Granted Sep 17, 2002·9 cites·22 claims
- 1072US6894059B1Compounds and methods for treatment of asthma, allergy and inflammatory disordersUCB SA·Filed 2000·Granted May 17, 2005·7 cites·11 claims
- 1171US12129250B2TYK2 inhibitors and compositions and methods thereofLYNK PHARMACEUTICALS CO LTD·Filed 2023·Granted Oct 29, 2024·0 cites·22 claims
- 1270US6093724AMuscarinic agonists and antagonistsUCB SA·Filed 1999·Granted Jul 25, 2000·20 cites·12 claims
- 1370US2025115597A1Tyk2 inhibitors and compositions and methods thereofLYNK PHARMACEUTICALS CO LTD·Filed 2024·Application pending·0 cites
- 1468US6797713B2Compounds and methods for treatment of asthma, allergy and inflammatory disordersUCB SA·Filed 2002·Granted Sep 28, 2004·3 cites·2 claims
- 1568US5681966ACompounds and methods for the treatment of cardiovascular, inflammatory and immune disordersCYTOMED INC·Filed 1995·Granted Oct 28, 1997·10 cites·50 claims
- 1666US6201016B1Compounds and methods for the treatment of cardiovascular, inflammatory and immune disordersCYTOMED INC·Filed 1995·Granted Mar 13, 2001·12 cites·15 claims
- 1752US2004048875A1Compounds and methods for treatment of asthma, allergy and inflammatory disordersUCB SA·Filed 2003·Application pending·0 cites
- 1846US2010029643A1Heterocyclyc sulfonamides having edg-1 antagonistic activityASTRAZENECA AB·Filed 2007·Application pending·0 cites
- 1944US2009111860A1Sulfonamide compounds useful as adg receptor modulatorsASTRAZENECA AB·Filed 2007·Application pending·0 cites
- 2043US2009105324A1Imidazole derivatives for use as edg-1 antagonistsASTRAZENECA AB·Filed 2007·Application pending·0 cites
- 2142US2010197749A1Chemical compoundsASTRAZENECA AB·Filed 2007·Application pending·0 cites
- 2240US2003055084A1Pharmaceutical compounds and methods of use thereofMILLENNIUM PHARM INC·Filed 2002·Application pending·0 cites
- 2338US6420392B1Compounds and methods for the treatment of cardiovascular, inflammatory and immune disordersMILLENNIUM PHARM INC·Filed 1995·Granted Jul 16, 2002·2 cites·11 claims
- 2433US2020165257A1Inhibitors of phosphoinositide 3-kinase and histone deacetylase for treatment of cancerTHE US SECRETARY DEPARTMENT OF HEALTH AND HUMAN SERVIC·Filed 2018·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →